Life ScienceCompany
Crealta Pharmaceuticals M&A Summary
Crealta Pharmaceuticals has acquired 1 company of its own. It has also divested 1 asset.
Crealta Pharmaceuticals’ largest acquisition to date was in 2013, when it acquired Savient Pharmaceuticals for $120M. Crealta Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Crealta Pharmaceuticals Ownership
Who owns Crealta Pharmaceuticals?
Crealta Pharmaceuticals is owned by Horizon Therapeutics Public Limited Company. It was acquired on December 11, 2015.
Was Crealta Pharmaceuticals formerly PE-backed?
Yes. Crealta Pharmaceuticals was formerly owned by 1 private investor.
Crealta Pharmaceuticals Business Overview
Where is Crealta Pharmaceuticals headquartered?
Crealta Pharmaceuticals is headquartered in Glendale, Wisconsin.
What sector is Crealta Pharmaceuticals in?
Crealta Pharmaceuticals is a life science company.
When was Crealta Pharmaceuticals founded?
Crealta Pharmaceuticals was founded in 2013.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
Unlimited Searches
